nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR6—Alzheimer's disease	0.296	0.64	CbGaD
Zuclopenthixol—HTR2A—Donepezil—Alzheimer's disease	0.113	0.362	CbGbCtD
Zuclopenthixol—DRD2—Memantine—Alzheimer's disease	0.0904	0.289	CbGbCtD
Zuclopenthixol—HTR2A—Alzheimer's disease	0.087	0.188	CbGaD
Zuclopenthixol—CYP2D6—Alzheimer's disease	0.0795	0.172	CbGaD
Zuclopenthixol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0471	0.151	CbGbCtD
Zuclopenthixol—CYP2D6—Donepezil—Alzheimer's disease	0.0377	0.12	CbGbCtD
Zuclopenthixol—CYP2D6—Galantamine—Alzheimer's disease	0.0243	0.0776	CbGbCtD
Zuclopenthixol—HTR2A—choroid plexus—Alzheimer's disease	0.00547	0.119	CbGeAlD
Zuclopenthixol—DRD1—telencephalic ventricle—Alzheimer's disease	0.00412	0.0892	CbGeAlD
Zuclopenthixol—HTR2A—locus ceruleus—Alzheimer's disease	0.00338	0.0733	CbGeAlD
Zuclopenthixol—HTR2A—cerebellar cortex—Alzheimer's disease	0.00276	0.0597	CbGeAlD
Zuclopenthixol—DRD2—telencephalic ventricle—Alzheimer's disease	0.00243	0.0527	CbGeAlD
Zuclopenthixol—HTR2A—telencephalic ventricle—Alzheimer's disease	0.0016	0.0347	CbGeAlD
Zuclopenthixol—HTR6—forebrain—Alzheimer's disease	0.00144	0.0313	CbGeAlD
Zuclopenthixol—DRD5—forebrain—Alzheimer's disease	0.00141	0.0305	CbGeAlD
Zuclopenthixol—HTR6—telencephalon—Alzheimer's disease	0.00133	0.0288	CbGeAlD
Zuclopenthixol—DRD5—telencephalon—Alzheimer's disease	0.00129	0.028	CbGeAlD
Zuclopenthixol—DRD1—forebrain—Alzheimer's disease	0.00107	0.0233	CbGeAlD
Zuclopenthixol—DRD1—telencephalon—Alzheimer's disease	0.000988	0.0214	CbGeAlD
Zuclopenthixol—HTR2A—blood vessel—Alzheimer's disease	0.000794	0.0172	CbGeAlD
Zuclopenthixol—HTR6—nervous system—Alzheimer's disease	0.000784	0.017	CbGeAlD
Zuclopenthixol—DRD5—nervous system—Alzheimer's disease	0.000764	0.0165	CbGeAlD
Zuclopenthixol—HTR6—central nervous system—Alzheimer's disease	0.000755	0.0164	CbGeAlD
Zuclopenthixol—DRD5—central nervous system—Alzheimer's disease	0.000735	0.0159	CbGeAlD
Zuclopenthixol—ADRA1A—forebrain—Alzheimer's disease	0.000648	0.014	CbGeAlD
Zuclopenthixol—DRD2—forebrain—Alzheimer's disease	0.000635	0.0138	CbGeAlD
Zuclopenthixol—HTR6—brain—Alzheimer's disease	0.0006	0.013	CbGeAlD
Zuclopenthixol—ADRA1A—telencephalon—Alzheimer's disease	0.000596	0.0129	CbGeAlD
Zuclopenthixol—DRD2—telencephalon—Alzheimer's disease	0.000584	0.0127	CbGeAlD
Zuclopenthixol—DRD5—brain—Alzheimer's disease	0.000584	0.0126	CbGeAlD
Zuclopenthixol—DRD1—nervous system—Alzheimer's disease	0.000583	0.0126	CbGeAlD
Zuclopenthixol—DRD1—central nervous system—Alzheimer's disease	0.000562	0.0122	CbGeAlD
Zuclopenthixol—HRH1—forebrain—Alzheimer's disease	0.000501	0.0109	CbGeAlD
Zuclopenthixol—ADRA2A—forebrain—Alzheimer's disease	0.000493	0.0107	CbGeAlD
Zuclopenthixol—HTR2A—embryo—Alzheimer's disease	0.000474	0.0103	CbGeAlD
Zuclopenthixol—HRH1—telencephalon—Alzheimer's disease	0.000461	0.00999	CbGeAlD
Zuclopenthixol—ADRA2A—telencephalon—Alzheimer's disease	0.000453	0.00981	CbGeAlD
Zuclopenthixol—DRD1—brain—Alzheimer's disease	0.000446	0.00966	CbGeAlD
Zuclopenthixol—HTR2A—forebrain—Alzheimer's disease	0.000419	0.00907	CbGeAlD
Zuclopenthixol—HTR2A—telencephalon—Alzheimer's disease	0.000385	0.00834	CbGeAlD
Zuclopenthixol—CYP2D6—forebrain—Alzheimer's disease	0.000382	0.00827	CbGeAlD
Zuclopenthixol—ADRA1A—nervous system—Alzheimer's disease	0.000352	0.00762	CbGeAlD
Zuclopenthixol—CYP2D6—telencephalon—Alzheimer's disease	0.000351	0.0076	CbGeAlD
Zuclopenthixol—DRD2—nervous system—Alzheimer's disease	0.000345	0.00747	CbGeAlD
Zuclopenthixol—ADRA1A—central nervous system—Alzheimer's disease	0.000339	0.00734	CbGeAlD
Zuclopenthixol—DRD2—central nervous system—Alzheimer's disease	0.000332	0.00719	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—Alzheimer's disease	0.000331	0.00717	CbGeAlD
Zuclopenthixol—DRD2—cerebellum—Alzheimer's disease	0.000324	0.00703	CbGeAlD
Zuclopenthixol—Neutropenia—Memantine—Alzheimer's disease	0.00028	0.00204	CcSEcCtD
Zuclopenthixol—Dysuria—Memantine—Alzheimer's disease	0.00028	0.00204	CcSEcCtD
Zuclopenthixol—Vision blurred—Galantamine—Alzheimer's disease	0.000279	0.00203	CcSEcCtD
Zuclopenthixol—Tremor—Galantamine—Alzheimer's disease	0.000278	0.00202	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Memantine—Alzheimer's disease	0.000275	0.00201	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000275	0.002	CcSEcCtD
Zuclopenthixol—Dysuria—Rivastigmine—Alzheimer's disease	0.000274	0.00199	CcSEcCtD
Zuclopenthixol—HRH1—nervous system—Alzheimer's disease	0.000272	0.0059	CbGeAlD
Zuclopenthixol—Weight increased—Memantine—Alzheimer's disease	0.000272	0.00198	CcSEcCtD
Zuclopenthixol—Agitation—Galantamine—Alzheimer's disease	0.000272	0.00198	CcSEcCtD
Zuclopenthixol—Weight decreased—Memantine—Alzheimer's disease	0.000271	0.00197	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Memantine—Alzheimer's disease	0.00027	0.00196	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00027	0.00196	CcSEcCtD
Zuclopenthixol—ADRA1A—brain—Alzheimer's disease	0.000269	0.00582	CbGeAlD
Zuclopenthixol—ADRA2A—nervous system—Alzheimer's disease	0.000267	0.00579	CbGeAlD
Zuclopenthixol—Malaise—Galantamine—Alzheimer's disease	0.000267	0.00195	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000267	0.00194	CcSEcCtD
Zuclopenthixol—Weight increased—Rivastigmine—Alzheimer's disease	0.000266	0.00194	CcSEcCtD
Zuclopenthixol—Vertigo—Galantamine—Alzheimer's disease	0.000266	0.00194	CcSEcCtD
Zuclopenthixol—Syncope—Galantamine—Alzheimer's disease	0.000266	0.00193	CcSEcCtD
Zuclopenthixol—Weight decreased—Rivastigmine—Alzheimer's disease	0.000265	0.00193	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000264	0.00192	CcSEcCtD
Zuclopenthixol—DRD2—brain—Alzheimer's disease	0.000263	0.00571	CbGeAlD
Zuclopenthixol—HRH1—central nervous system—Alzheimer's disease	0.000262	0.00568	CbGeAlD
Zuclopenthixol—Palpitations—Galantamine—Alzheimer's disease	0.000262	0.00191	CcSEcCtD
Zuclopenthixol—Drowsiness—Rivastigmine—Alzheimer's disease	0.000261	0.0019	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00026	0.0019	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00026	0.0019	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Donepezil—Alzheimer's disease	0.00026	0.00189	CcSEcCtD
Zuclopenthixol—Urethral disorder—Donepezil—Alzheimer's disease	0.000258	0.00188	CcSEcCtD
Zuclopenthixol—ADRA2A—central nervous system—Alzheimer's disease	0.000257	0.00558	CbGeAlD
Zuclopenthixol—Convulsion—Galantamine—Alzheimer's disease	0.000257	0.00187	CcSEcCtD
Zuclopenthixol—Hypertension—Galantamine—Alzheimer's disease	0.000256	0.00186	CcSEcCtD
Zuclopenthixol—Visual impairment—Donepezil—Alzheimer's disease	0.000254	0.00185	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Zuclopenthixol—Myalgia—Galantamine—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Zuclopenthixol—ADRA2A—cerebellum—Alzheimer's disease	0.000252	0.00545	CbGeAlD
Zuclopenthixol—Anxiety—Galantamine—Alzheimer's disease	0.000251	0.00183	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00025	0.00182	CcSEcCtD
Zuclopenthixol—Sweating—Rivastigmine—Alzheimer's disease	0.00025	0.00182	CcSEcCtD
Zuclopenthixol—Discomfort—Galantamine—Alzheimer's disease	0.000249	0.00181	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Memantine—Alzheimer's disease	0.000249	0.00181	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000247	0.0018	CcSEcCtD
Zuclopenthixol—Dry mouth—Galantamine—Alzheimer's disease	0.000247	0.0018	CcSEcCtD
Zuclopenthixol—Tinnitus—Donepezil—Alzheimer's disease	0.000246	0.00179	CcSEcCtD
Zuclopenthixol—Shock—Galantamine—Alzheimer's disease	0.000238	0.00173	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000237	0.00173	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000237	0.00172	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000236	0.00172	CcSEcCtD
Zuclopenthixol—Tachycardia—Galantamine—Alzheimer's disease	0.000236	0.00172	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Memantine—Alzheimer's disease	0.000236	0.00172	CcSEcCtD
Zuclopenthixol—Arrhythmia—Donepezil—Alzheimer's disease	0.000236	0.00172	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000235	0.00171	CcSEcCtD
Zuclopenthixol—Skin disorder—Galantamine—Alzheimer's disease	0.000235	0.00171	CcSEcCtD
Zuclopenthixol—Urethral disorder—Memantine—Alzheimer's disease	0.000235	0.00171	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000234	0.0017	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000231	0.00168	CcSEcCtD
Zuclopenthixol—Mental disorder—Donepezil—Alzheimer's disease	0.000231	0.00168	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000231	0.00168	CcSEcCtD
Zuclopenthixol—Visual impairment—Memantine—Alzheimer's disease	0.000231	0.00168	CcSEcCtD
Zuclopenthixol—Anorexia—Galantamine—Alzheimer's disease	0.00023	0.00168	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00023	0.00168	CcSEcCtD
Zuclopenthixol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00023	0.00167	CcSEcCtD
Zuclopenthixol—Erythema—Donepezil—Alzheimer's disease	0.00023	0.00167	CcSEcCtD
Zuclopenthixol—Malnutrition—Donepezil—Alzheimer's disease	0.00023	0.00167	CcSEcCtD
Zuclopenthixol—HTR2A—nervous system—Alzheimer's disease	0.000227	0.00493	CbGeAlD
Zuclopenthixol—Flatulence—Donepezil—Alzheimer's disease	0.000226	0.00165	CcSEcCtD
Zuclopenthixol—Hypotension—Galantamine—Alzheimer's disease	0.000226	0.00164	CcSEcCtD
Zuclopenthixol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000226	0.00164	CcSEcCtD
Zuclopenthixol—Tension—Donepezil—Alzheimer's disease	0.000225	0.00164	CcSEcCtD
Zuclopenthixol—Eye disorder—Memantine—Alzheimer's disease	0.000224	0.00163	CcSEcCtD
Zuclopenthixol—Tinnitus—Memantine—Alzheimer's disease	0.000223	0.00163	CcSEcCtD
Zuclopenthixol—Nervousness—Donepezil—Alzheimer's disease	0.000223	0.00162	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Memantine—Alzheimer's disease	0.000222	0.00162	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00022	0.0016	CcSEcCtD
Zuclopenthixol—HTR2A—central nervous system—Alzheimer's disease	0.000219	0.00474	CbGeAlD
Zuclopenthixol—Eye disorder—Rivastigmine—Alzheimer's disease	0.000219	0.00159	CcSEcCtD
Zuclopenthixol—Insomnia—Galantamine—Alzheimer's disease	0.000219	0.00159	CcSEcCtD
Zuclopenthixol—Tinnitus—Rivastigmine—Alzheimer's disease	0.000218	0.00159	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000217	0.00158	CcSEcCtD
Zuclopenthixol—Angiopathy—Memantine—Alzheimer's disease	0.000217	0.00158	CcSEcCtD
Zuclopenthixol—Paraesthesia—Galantamine—Alzheimer's disease	0.000217	0.00158	CcSEcCtD
Zuclopenthixol—Vision blurred—Donepezil—Alzheimer's disease	0.000216	0.00158	CcSEcCtD
Zuclopenthixol—Immune system disorder—Memantine—Alzheimer's disease	0.000216	0.00157	CcSEcCtD
Zuclopenthixol—Tremor—Donepezil—Alzheimer's disease	0.000215	0.00157	CcSEcCtD
Zuclopenthixol—Somnolence—Galantamine—Alzheimer's disease	0.000215	0.00156	CcSEcCtD
Zuclopenthixol—HTR2A—cerebellum—Alzheimer's disease	0.000214	0.00464	CbGeAlD
Zuclopenthixol—Arrhythmia—Memantine—Alzheimer's disease	0.000214	0.00156	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000213	0.00155	CcSEcCtD
Zuclopenthixol—Dyspepsia—Galantamine—Alzheimer's disease	0.000213	0.00155	CcSEcCtD
Zuclopenthixol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000213	0.00155	CcSEcCtD
Zuclopenthixol—Agitation—Donepezil—Alzheimer's disease	0.000211	0.00154	CcSEcCtD
Zuclopenthixol—Decreased appetite—Galantamine—Alzheimer's disease	0.00021	0.00153	CcSEcCtD
Zuclopenthixol—Mental disorder—Memantine—Alzheimer's disease	0.00021	0.00153	CcSEcCtD
Zuclopenthixol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000209	0.00152	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000209	0.00152	CcSEcCtD
Zuclopenthixol—Malnutrition—Memantine—Alzheimer's disease	0.000208	0.00152	CcSEcCtD
Zuclopenthixol—Fatigue—Galantamine—Alzheimer's disease	0.000208	0.00152	CcSEcCtD
Zuclopenthixol—HRH1—brain—Alzheimer's disease	0.000208	0.00451	CbGeAlD
Zuclopenthixol—CYP2D6—nervous system—Alzheimer's disease	0.000207	0.00449	CbGeAlD
Zuclopenthixol—Malaise—Donepezil—Alzheimer's disease	0.000207	0.00151	CcSEcCtD
Zuclopenthixol—Constipation—Galantamine—Alzheimer's disease	0.000207	0.00151	CcSEcCtD
Zuclopenthixol—Vertigo—Donepezil—Alzheimer's disease	0.000206	0.0015	CcSEcCtD
Zuclopenthixol—Syncope—Donepezil—Alzheimer's disease	0.000206	0.0015	CcSEcCtD
Zuclopenthixol—Flatulence—Memantine—Alzheimer's disease	0.000205	0.0015	CcSEcCtD
Zuclopenthixol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000205	0.00149	CcSEcCtD
Zuclopenthixol—Tension—Memantine—Alzheimer's disease	0.000205	0.00149	CcSEcCtD
Zuclopenthixol—ADRA2A—brain—Alzheimer's disease	0.000204	0.00443	CbGeAlD
Zuclopenthixol—Erythema—Rivastigmine—Alzheimer's disease	0.000204	0.00148	CcSEcCtD
Zuclopenthixol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000204	0.00148	CcSEcCtD
Zuclopenthixol—Nervousness—Memantine—Alzheimer's disease	0.000202	0.00147	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000202	0.00147	CcSEcCtD
Zuclopenthixol—Flatulence—Rivastigmine—Alzheimer's disease	0.000201	0.00146	CcSEcCtD
Zuclopenthixol—Tension—Rivastigmine—Alzheimer's disease	0.0002	0.00146	CcSEcCtD
Zuclopenthixol—CYP2D6—central nervous system—Alzheimer's disease	0.000199	0.00432	CbGeAlD
Zuclopenthixol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000199	0.00145	CcSEcCtD
Zuclopenthixol—Convulsion—Donepezil—Alzheimer's disease	0.000199	0.00145	CcSEcCtD
Zuclopenthixol—Hypertension—Donepezil—Alzheimer's disease	0.000198	0.00144	CcSEcCtD
Zuclopenthixol—Nervousness—Rivastigmine—Alzheimer's disease	0.000198	0.00144	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000198	0.00144	CcSEcCtD
Zuclopenthixol—Vision blurred—Memantine—Alzheimer's disease	0.000196	0.00143	CcSEcCtD
Zuclopenthixol—Thiothixene—HTR6—Alzheimer's disease	0.000196	0.048	CrCbGaD
Zuclopenthixol—Myalgia—Donepezil—Alzheimer's disease	0.000195	0.00142	CcSEcCtD
Zuclopenthixol—Tremor—Memantine—Alzheimer's disease	0.000195	0.00142	CcSEcCtD
Zuclopenthixol—CYP2D6—cerebellum—Alzheimer's disease	0.000195	0.00422	CbGeAlD
Zuclopenthixol—Anxiety—Donepezil—Alzheimer's disease	0.000195	0.00142	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000193	0.00141	CcSEcCtD
Zuclopenthixol—Discomfort—Donepezil—Alzheimer's disease	0.000193	0.00141	CcSEcCtD
Zuclopenthixol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000192	0.0014	CcSEcCtD
Zuclopenthixol—Agitation—Memantine—Alzheimer's disease	0.000192	0.00139	CcSEcCtD
Zuclopenthixol—Dry mouth—Donepezil—Alzheimer's disease	0.000191	0.00139	CcSEcCtD
Zuclopenthixol—Abdominal pain—Galantamine—Alzheimer's disease	0.000191	0.00139	CcSEcCtD
Zuclopenthixol—Body temperature increased—Galantamine—Alzheimer's disease	0.000191	0.00139	CcSEcCtD
Zuclopenthixol—Tremor—Rivastigmine—Alzheimer's disease	0.000191	0.00139	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000189	0.00138	CcSEcCtD
Zuclopenthixol—Fluphenazine—CALM1—Alzheimer's disease	0.000188	0.0459	CrCbGaD
Zuclopenthixol—Malaise—Memantine—Alzheimer's disease	0.000188	0.00137	CcSEcCtD
Zuclopenthixol—Agitation—Rivastigmine—Alzheimer's disease	0.000187	0.00136	CcSEcCtD
Zuclopenthixol—Vertigo—Memantine—Alzheimer's disease	0.000187	0.00136	CcSEcCtD
Zuclopenthixol—Syncope—Memantine—Alzheimer's disease	0.000187	0.00136	CcSEcCtD
Zuclopenthixol—Leukopenia—Memantine—Alzheimer's disease	0.000187	0.00136	CcSEcCtD
Zuclopenthixol—Shock—Donepezil—Alzheimer's disease	0.000184	0.00134	CcSEcCtD
Zuclopenthixol—Palpitations—Memantine—Alzheimer's disease	0.000184	0.00134	CcSEcCtD
Zuclopenthixol—Malaise—Rivastigmine—Alzheimer's disease	0.000184	0.00134	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000184	0.00134	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000183	0.00134	CcSEcCtD
Zuclopenthixol—Vertigo—Rivastigmine—Alzheimer's disease	0.000183	0.00133	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Memantine—Alzheimer's disease	0.000183	0.00133	CcSEcCtD
Zuclopenthixol—Syncope—Rivastigmine—Alzheimer's disease	0.000183	0.00133	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000181	0.00132	CcSEcCtD
Zuclopenthixol—Convulsion—Memantine—Alzheimer's disease	0.000181	0.00131	CcSEcCtD
Zuclopenthixol—Palpitations—Rivastigmine—Alzheimer's disease	0.00018	0.00131	CcSEcCtD
Zuclopenthixol—Hypertension—Memantine—Alzheimer's disease	0.00018	0.00131	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000179	0.0013	CcSEcCtD
Zuclopenthixol—Anorexia—Donepezil—Alzheimer's disease	0.000179	0.0013	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000178	0.0013	CcSEcCtD
Zuclopenthixol—Myalgia—Memantine—Alzheimer's disease	0.000177	0.00129	CcSEcCtD
Zuclopenthixol—Anxiety—Memantine—Alzheimer's disease	0.000177	0.00129	CcSEcCtD
Zuclopenthixol—Convulsion—Rivastigmine—Alzheimer's disease	0.000177	0.00129	CcSEcCtD
Zuclopenthixol—Hypertension—Rivastigmine—Alzheimer's disease	0.000176	0.00128	CcSEcCtD
Zuclopenthixol—Discomfort—Memantine—Alzheimer's disease	0.000175	0.00128	CcSEcCtD
Zuclopenthixol—Hypotension—Donepezil—Alzheimer's disease	0.000175	0.00127	CcSEcCtD
Zuclopenthixol—HTR2A—brain—Alzheimer's disease	0.000174	0.00377	CbGeAlD
Zuclopenthixol—Myalgia—Rivastigmine—Alzheimer's disease	0.000174	0.00126	CcSEcCtD
Zuclopenthixol—Dry mouth—Memantine—Alzheimer's disease	0.000174	0.00126	CcSEcCtD
Zuclopenthixol—Asthenia—Galantamine—Alzheimer's disease	0.000173	0.00126	CcSEcCtD
Zuclopenthixol—Anxiety—Rivastigmine—Alzheimer's disease	0.000173	0.00126	CcSEcCtD
Zuclopenthixol—Amoxapine—HTR6—Alzheimer's disease	0.000172	0.0422	CrCbGaD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000172	0.00126	CcSEcCtD
Zuclopenthixol—Discomfort—Rivastigmine—Alzheimer's disease	0.000172	0.00125	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000171	0.00124	CcSEcCtD
Zuclopenthixol—Dry mouth—Rivastigmine—Alzheimer's disease	0.00017	0.00124	CcSEcCtD
Zuclopenthixol—Fluphenazine—HTR6—Alzheimer's disease	0.00017	0.0414	CrCbGaD
Zuclopenthixol—Insomnia—Donepezil—Alzheimer's disease	0.000169	0.00123	CcSEcCtD
Zuclopenthixol—Paraesthesia—Donepezil—Alzheimer's disease	0.000168	0.00122	CcSEcCtD
Zuclopenthixol—Shock—Memantine—Alzheimer's disease	0.000167	0.00122	CcSEcCtD
Zuclopenthixol—Dyspnoea—Donepezil—Alzheimer's disease	0.000167	0.00122	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Memantine—Alzheimer's disease	0.000167	0.00121	CcSEcCtD
Zuclopenthixol—Somnolence—Donepezil—Alzheimer's disease	0.000167	0.00121	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000167	0.00121	CcSEcCtD
Zuclopenthixol—Tachycardia—Memantine—Alzheimer's disease	0.000166	0.00121	CcSEcCtD
Zuclopenthixol—Diarrhoea—Galantamine—Alzheimer's disease	0.000165	0.0012	CcSEcCtD
Zuclopenthixol—Skin disorder—Memantine—Alzheimer's disease	0.000165	0.0012	CcSEcCtD
Zuclopenthixol—Dyspepsia—Donepezil—Alzheimer's disease	0.000165	0.0012	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000164	0.0012	CcSEcCtD
Zuclopenthixol—Shock—Rivastigmine—Alzheimer's disease	0.000164	0.00119	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000163	0.00119	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000163	0.00119	CcSEcCtD
Zuclopenthixol—Decreased appetite—Donepezil—Alzheimer's disease	0.000163	0.00119	CcSEcCtD
Zuclopenthixol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Zuclopenthixol—Anorexia—Memantine—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Zuclopenthixol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Zuclopenthixol—Fatigue—Donepezil—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000161	0.00117	CcSEcCtD
Zuclopenthixol—Pain—Donepezil—Alzheimer's disease	0.00016	0.00117	CcSEcCtD
Zuclopenthixol—Constipation—Donepezil—Alzheimer's disease	0.00016	0.00117	CcSEcCtD
Zuclopenthixol—Dizziness—Galantamine—Alzheimer's disease	0.00016	0.00116	CcSEcCtD
Zuclopenthixol—Hypotension—Memantine—Alzheimer's disease	0.000159	0.00116	CcSEcCtD
Zuclopenthixol—Anorexia—Rivastigmine—Alzheimer's disease	0.000159	0.00116	CcSEcCtD
Zuclopenthixol—CYP2D6—brain—Alzheimer's disease	0.000158	0.00343	CbGeAlD
Zuclopenthixol—Hypotension—Rivastigmine—Alzheimer's disease	0.000155	0.00113	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000155	0.00113	CcSEcCtD
Zuclopenthixol—Chlorprothixene—HTR6—Alzheimer's disease	0.000154	0.0377	CrCbGaD
Zuclopenthixol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000154	0.00112	CcSEcCtD
Zuclopenthixol—Insomnia—Memantine—Alzheimer's disease	0.000154	0.00112	CcSEcCtD
Zuclopenthixol—Vomiting—Galantamine—Alzheimer's disease	0.000154	0.00112	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000153	0.00112	CcSEcCtD
Zuclopenthixol—Paraesthesia—Memantine—Alzheimer's disease	0.000153	0.00111	CcSEcCtD
Zuclopenthixol—Rash—Galantamine—Alzheimer's disease	0.000152	0.00111	CcSEcCtD
Zuclopenthixol—Dermatitis—Galantamine—Alzheimer's disease	0.000152	0.00111	CcSEcCtD
Zuclopenthixol—Dyspnoea—Memantine—Alzheimer's disease	0.000152	0.0011	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000152	0.0011	CcSEcCtD
Zuclopenthixol—Headache—Galantamine—Alzheimer's disease	0.000151	0.0011	CcSEcCtD
Zuclopenthixol—Somnolence—Memantine—Alzheimer's disease	0.000151	0.0011	CcSEcCtD
Zuclopenthixol—Insomnia—Rivastigmine—Alzheimer's disease	0.000151	0.0011	CcSEcCtD
Zuclopenthixol—Trifluoperazine—CALM1—Alzheimer's disease	0.00015	0.0367	CrCbGaD
Zuclopenthixol—Dyspepsia—Memantine—Alzheimer's disease	0.00015	0.00109	CcSEcCtD
Zuclopenthixol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000149	0.00109	CcSEcCtD
Zuclopenthixol—Perphenazine—CALM1—Alzheimer's disease	0.000149	0.0363	CrCbGaD
Zuclopenthixol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000148	0.00108	CcSEcCtD
Zuclopenthixol—Abdominal pain—Donepezil—Alzheimer's disease	0.000148	0.00108	CcSEcCtD
Zuclopenthixol—Body temperature increased—Donepezil—Alzheimer's disease	0.000148	0.00108	CcSEcCtD
Zuclopenthixol—Somnolence—Rivastigmine—Alzheimer's disease	0.000148	0.00108	CcSEcCtD
Zuclopenthixol—Decreased appetite—Memantine—Alzheimer's disease	0.000148	0.00108	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000147	0.00107	CcSEcCtD
Zuclopenthixol—Fatigue—Memantine—Alzheimer's disease	0.000147	0.00107	CcSEcCtD
Zuclopenthixol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000146	0.00107	CcSEcCtD
Zuclopenthixol—Thioridazine—HTR6—Alzheimer's disease	0.000146	0.0357	CrCbGaD
Zuclopenthixol—Constipation—Memantine—Alzheimer's disease	0.000145	0.00106	CcSEcCtD
Zuclopenthixol—Pain—Memantine—Alzheimer's disease	0.000145	0.00106	CcSEcCtD
Zuclopenthixol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000145	0.00105	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000144	0.00105	CcSEcCtD
Zuclopenthixol—Nausea—Galantamine—Alzheimer's disease	0.000144	0.00105	CcSEcCtD
Zuclopenthixol—Fatigue—Rivastigmine—Alzheimer's disease	0.000143	0.00104	CcSEcCtD
Zuclopenthixol—Pain—Rivastigmine—Alzheimer's disease	0.000142	0.00104	CcSEcCtD
Zuclopenthixol—Constipation—Rivastigmine—Alzheimer's disease	0.000142	0.00104	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Memantine—Alzheimer's disease	0.00014	0.00102	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000139	0.00101	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000138	0.00101	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000137	0.000999	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000136	0.000991	CcSEcCtD
Zuclopenthixol—Trifluoperazine—HTR6—Alzheimer's disease	0.000136	0.0331	CrCbGaD
Zuclopenthixol—Loxapine—HTR6—Alzheimer's disease	0.000135	0.0329	CrCbGaD
Zuclopenthixol—Body temperature increased—Memantine—Alzheimer's disease	0.000134	0.000979	CcSEcCtD
Zuclopenthixol—Abdominal pain—Memantine—Alzheimer's disease	0.000134	0.000979	CcSEcCtD
Zuclopenthixol—Asthenia—Donepezil—Alzheimer's disease	0.000134	0.000979	CcSEcCtD
Zuclopenthixol—Perphenazine—HTR6—Alzheimer's disease	0.000134	0.0328	CrCbGaD
Zuclopenthixol—Pruritus—Donepezil—Alzheimer's disease	0.000133	0.000965	CcSEcCtD
Zuclopenthixol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000132	0.000958	CcSEcCtD
Zuclopenthixol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000132	0.000958	CcSEcCtD
Zuclopenthixol—Quetiapine—HTR6—Alzheimer's disease	0.000131	0.0321	CrCbGaD
Zuclopenthixol—Diarrhoea—Donepezil—Alzheimer's disease	0.000128	0.000933	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Memantine—Alzheimer's disease	0.000125	0.000913	CcSEcCtD
Zuclopenthixol—Dizziness—Donepezil—Alzheimer's disease	0.000124	0.000902	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000123	0.000893	CcSEcCtD
Zuclopenthixol—Asthenia—Memantine—Alzheimer's disease	0.000122	0.000889	CcSEcCtD
Zuclopenthixol—Pruritus—Memantine—Alzheimer's disease	0.00012	0.000876	CcSEcCtD
Zuclopenthixol—Asthenia—Rivastigmine—Alzheimer's disease	0.000119	0.000869	CcSEcCtD
Zuclopenthixol—Flupentixol—HTR2A—Alzheimer's disease	0.000119	0.0291	CrCbGaD
Zuclopenthixol—Vomiting—Donepezil—Alzheimer's disease	0.000119	0.000867	CcSEcCtD
Zuclopenthixol—Rash—Donepezil—Alzheimer's disease	0.000118	0.00086	CcSEcCtD
Zuclopenthixol—Dermatitis—Donepezil—Alzheimer's disease	0.000118	0.000859	CcSEcCtD
Zuclopenthixol—Chlorpromazine—CALM1—Alzheimer's disease	0.000118	0.0288	CrCbGaD
Zuclopenthixol—Pruritus—Rivastigmine—Alzheimer's disease	0.000118	0.000857	CcSEcCtD
Zuclopenthixol—Headache—Donepezil—Alzheimer's disease	0.000117	0.000855	CcSEcCtD
Zuclopenthixol—Diarrhoea—Memantine—Alzheimer's disease	0.000116	0.000847	CcSEcCtD
Zuclopenthixol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000114	0.000829	CcSEcCtD
Zuclopenthixol—Hydroxyzine—CYP2D6—Alzheimer's disease	0.000114	0.0278	CrCbGaD
Zuclopenthixol—Clozapine—HTR6—Alzheimer's disease	0.000113	0.0276	CrCbGaD
Zuclopenthixol—Dizziness—Memantine—Alzheimer's disease	0.000112	0.000819	CcSEcCtD
Zuclopenthixol—Nausea—Donepezil—Alzheimer's disease	0.000111	0.00081	CcSEcCtD
Zuclopenthixol—Dizziness—Rivastigmine—Alzheimer's disease	0.00011	0.000801	CcSEcCtD
Zuclopenthixol—Vomiting—Memantine—Alzheimer's disease	0.000108	0.000788	CcSEcCtD
Zuclopenthixol—Rash—Memantine—Alzheimer's disease	0.000107	0.000781	CcSEcCtD
Zuclopenthixol—Dermatitis—Memantine—Alzheimer's disease	0.000107	0.00078	CcSEcCtD
Zuclopenthixol—Headache—Memantine—Alzheimer's disease	0.000107	0.000776	CcSEcCtD
Zuclopenthixol—Chlorpromazine—HTR6—Alzheimer's disease	0.000106	0.026	CrCbGaD
Zuclopenthixol—Vomiting—Rivastigmine—Alzheimer's disease	0.000106	0.00077	CcSEcCtD
Zuclopenthixol—Rash—Rivastigmine—Alzheimer's disease	0.000105	0.000764	CcSEcCtD
Zuclopenthixol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000105	0.000763	CcSEcCtD
Zuclopenthixol—Headache—Rivastigmine—Alzheimer's disease	0.000104	0.000759	CcSEcCtD
Zuclopenthixol—Nausea—Memantine—Alzheimer's disease	0.000101	0.000736	CcSEcCtD
Zuclopenthixol—Nausea—Rivastigmine—Alzheimer's disease	9.88e-05	0.00072	CcSEcCtD
Zuclopenthixol—Nefazodone—SLC6A4—Alzheimer's disease	8.66e-05	0.0212	CrCbGaD
Zuclopenthixol—Trazodone—SLC6A4—Alzheimer's disease	8.01e-05	0.0196	CrCbGaD
Zuclopenthixol—Domperidone—CYP2D6—Alzheimer's disease	7.33e-05	0.0179	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2A—Alzheimer's disease	6.66e-05	0.0163	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—Alzheimer's disease	6.6e-05	0.0161	CrCbGaD
Zuclopenthixol—Trazodone—HTR2A—Alzheimer's disease	6.16e-05	0.0151	CrCbGaD
Zuclopenthixol—Nefazodone—CYP2D6—Alzheimer's disease	6.09e-05	0.0149	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR2A—Alzheimer's disease	5.87e-05	0.0143	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—Alzheimer's disease	5.77e-05	0.0141	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—Alzheimer's disease	5.77e-05	0.0141	CrCbGaD
Zuclopenthixol—Trazodone—CYP2D6—Alzheimer's disease	5.63e-05	0.0138	CrCbGaD
Zuclopenthixol—Thiothixene—CYP2D6—Alzheimer's disease	5.28e-05	0.0129	CrCbGaD
Zuclopenthixol—Pipotiazine—CYP2D6—Alzheimer's disease	5.28e-05	0.0129	CrCbGaD
Zuclopenthixol—Chlorpromazine—BCHE—Alzheimer's disease	5.22e-05	0.0127	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A4—Alzheimer's disease	5.16e-05	0.0126	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—Alzheimer's disease	5.07e-05	0.0124	CrCbGaD
Zuclopenthixol—Prochlorperazine—CYP2D6—Alzheimer's disease	5.04e-05	0.0123	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2A—Alzheimer's disease	4.99e-05	0.0122	CrCbGaD
Zuclopenthixol—Amoxapine—CYP2D6—Alzheimer's disease	4.64e-05	0.0113	CrCbGaD
Zuclopenthixol—Fluphenazine—CYP2D6—Alzheimer's disease	4.56e-05	0.0111	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2A—Alzheimer's disease	4.54e-05	0.0111	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2A—Alzheimer's disease	4.3e-05	0.0105	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2A—Alzheimer's disease	3.99e-05	0.00975	CrCbGaD
Zuclopenthixol—Loxapine—HTR2A—Alzheimer's disease	3.96e-05	0.00969	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2A—Alzheimer's disease	3.94e-05	0.00964	CrCbGaD
Zuclopenthixol—Thioridazine—CYP2D6—Alzheimer's disease	3.93e-05	0.00961	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2A—Alzheimer's disease	3.87e-05	0.00945	CrCbGaD
Zuclopenthixol—Perphenazine—CYP2D6—Alzheimer's disease	3.61e-05	0.00882	CrCbGaD
Zuclopenthixol—Quetiapine—CYP2D6—Alzheimer's disease	3.54e-05	0.00865	CrCbGaD
Zuclopenthixol—Clozapine—HTR2A—Alzheimer's disease	3.33e-05	0.00813	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2A—Alzheimer's disease	3.13e-05	0.00765	CrCbGaD
Zuclopenthixol—Clozapine—CYP2D6—Alzheimer's disease	3.04e-05	0.00744	CrCbGaD
Zuclopenthixol—Chlorpromazine—CYP2D6—Alzheimer's disease	2.86e-05	0.00699	CrCbGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	6.21e-06	0.000165	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	6.2e-06	0.000165	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	6.19e-06	0.000164	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	6.19e-06	0.000164	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	6.1e-06	0.000162	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	6.07e-06	0.000161	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—S100B—Alzheimer's disease	5.99e-06	0.000159	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—GSK3B—Alzheimer's disease	5.9e-06	0.000157	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	5.9e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	5.89e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CALM1—Alzheimer's disease	5.89e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—S100B—Alzheimer's disease	5.88e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APOE—Alzheimer's disease	5.87e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LEP—Alzheimer's disease	5.87e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CREB1—Alzheimer's disease	5.86e-06	0.000155	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.83e-06	0.000155	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—INS—Alzheimer's disease	5.82e-06	0.000155	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CAV1—Alzheimer's disease	5.82e-06	0.000154	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	5.81e-06	0.000154	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	5.8e-06	0.000154	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	5.77e-06	0.000153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	5.77e-06	0.000153	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL2—Alzheimer's disease	5.73e-06	0.000152	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	5.7e-06	0.000151	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—AKT1—Alzheimer's disease	5.67e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	5.67e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—LPL—Alzheimer's disease	5.66e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	5.64e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1—Alzheimer's disease	5.63e-06	0.000149	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CASP3—Alzheimer's disease	5.62e-06	0.000149	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	5.61e-06	0.000149	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	5.6e-06	0.000149	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	5.6e-06	0.000149	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—Alzheimer's disease	5.58e-06	0.000148	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—F2—Alzheimer's disease	5.53e-06	0.000147	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.53e-06	0.000147	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.53e-06	0.000147	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	5.51e-06	0.000146	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	5.49e-06	0.000146	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	5.43e-06	0.000144	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.42e-06	0.000144	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	5.41e-06	0.000144	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	5.36e-06	0.000142	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	5.31e-06	0.000141	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LPL—Alzheimer's disease	5.29e-06	0.00014	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	5.24e-06	0.000139	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	5.2e-06	0.000138	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LPL—Alzheimer's disease	5.19e-06	0.000138	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MAPK8—Alzheimer's disease	5.16e-06	0.000137	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	5.16e-06	0.000137	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—AKT1—Alzheimer's disease	5.15e-06	0.000137	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	5.14e-06	0.000136	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	5.14e-06	0.000136	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.14e-06	0.000136	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NOS3—Alzheimer's disease	5.11e-06	0.000136	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	5.11e-06	0.000135	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	5.1e-06	0.000135	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	5.09e-06	0.000135	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	5.08e-06	0.000135	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	5.06e-06	0.000134	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	5.05e-06	0.000134	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	5.05e-06	0.000134	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	5.04e-06	0.000134	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—INS—Alzheimer's disease	5.01e-06	0.000133	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NGF—Alzheimer's disease	5.01e-06	0.000133	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	4.95e-06	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	4.94e-06	0.000131	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	4.93e-06	0.000131	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	4.93e-06	0.000131	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NGF—Alzheimer's disease	4.92e-06	0.00013	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	4.87e-06	0.000129	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	4.85e-06	0.000129	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.85e-06	0.000129	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	4.82e-06	0.000128	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	4.79e-06	0.000127	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	4.78e-06	0.000127	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TP53—Alzheimer's disease	4.77e-06	0.000127	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—VEGFA—Alzheimer's disease	4.77e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	4.77e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CALM1—Alzheimer's disease	4.76e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APOE—Alzheimer's disease	4.74e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	4.73e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CAV1—Alzheimer's disease	4.7e-06	0.000125	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.7e-06	0.000125	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	4.69e-06	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.69e-06	0.000124	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	4.68e-06	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.6e-06	0.000122	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	4.59e-06	0.000122	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	4.48e-06	0.000119	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	4.45e-06	0.000118	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LEP—Alzheimer's disease	4.43e-06	0.000118	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOE—Alzheimer's disease	4.43e-06	0.000118	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	4.4e-06	0.000117	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	4.39e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AKT1—Alzheimer's disease	4.38e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—Alzheimer's disease	4.38e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	4.38e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.37e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	4.36e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	4.36e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	4.36e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.35e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.35e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CASP3—Alzheimer's disease	4.34e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	4.32e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.31e-06	0.000114	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—Alzheimer's disease	4.31e-06	0.000114	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	4.28e-06	0.000114	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	4.27e-06	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	4.27e-06	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	4.27e-06	0.000113	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	4.23e-06	0.000112	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	4.23e-06	0.000112	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—F2—Alzheimer's disease	4.18e-06	0.000111	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	4.16e-06	0.00011	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.15e-06	0.00011	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARG—Alzheimer's disease	4.13e-06	0.00011	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—F2—Alzheimer's disease	4.11e-06	0.000109	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.1e-06	0.000109	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.09e-06	0.000108	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	4.08e-06	0.000108	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—INS—Alzheimer's disease	4.05e-06	0.000108	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.05e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.03e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	4.03e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	4.03e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.02e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.02e-06	0.000107	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	3.99e-06	0.000106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.98e-06	0.000106	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	3.97e-06	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.97e-06	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.97e-06	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.94e-06	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.93e-06	0.000104	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	3.84e-06	0.000102	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	3.81e-06	0.000101	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.79e-06	0.0001	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—INS—Alzheimer's disease	3.79e-06	0.0001	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.78e-06	0.0001	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.77e-06	0.0001	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.77e-06	0.0001	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.75e-06	9.94e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.74e-06	9.92e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.74e-06	9.92e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	3.73e-06	9.9e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.72e-06	9.88e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	3.72e-06	9.88e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.72e-06	9.86e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	3.71e-06	9.84e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.7e-06	9.81e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.69e-06	9.78e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	3.68e-06	9.76e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.67e-06	9.73e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.66e-06	9.72e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	3.66e-06	9.71e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.66e-06	9.71e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.66e-06	9.7e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.65e-06	9.68e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	3.6e-06	9.56e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—Alzheimer's disease	3.6e-06	9.56e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.6e-06	9.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.59e-06	9.52e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.55e-06	9.43e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.53e-06	9.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.44e-06	9.11e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	3.43e-06	9.1e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	3.42e-06	9.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.41e-06	9.04e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	3.39e-06	8.99e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	3.38e-06	8.96e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.33e-06	8.85e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.32e-06	8.81e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	3.32e-06	8.81e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—Alzheimer's disease	3.3e-06	8.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	3.28e-06	8.7e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	3.27e-06	8.67e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.26e-06	8.65e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	3.25e-06	8.62e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.2e-06	8.49e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	3.17e-06	8.4e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.1e-06	8.23e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.09e-06	8.2e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.06e-06	8.13e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	3.04e-06	8.07e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.97e-06	7.88e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.91e-06	7.71e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.84e-06	7.55e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.82e-06	7.48e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.8e-06	7.43e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.8e-06	7.43e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.79e-06	7.41e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—Alzheimer's disease	2.78e-06	7.38e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.77e-06	7.36e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.77e-06	7.34e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.76e-06	7.31e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.75e-06	7.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.74e-06	7.27e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.72e-06	7.2e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.7e-06	7.16e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.69e-06	7.14e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INS—Alzheimer's disease	2.64e-06	7.01e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.59e-06	6.87e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.58e-06	6.85e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.55e-06	6.76e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.55e-06	6.76e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—Alzheimer's disease	2.55e-06	6.75e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.54e-06	6.75e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.54e-06	6.74e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.54e-06	6.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.52e-06	6.69e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.51e-06	6.65e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.5e-06	6.62e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.49e-06	6.6e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—Alzheimer's disease	2.39e-06	6.35e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	2.39e-06	6.34e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.35e-06	6.24e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.35e-06	6.23e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	2.35e-06	6.23e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.32e-06	6.15e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.32e-06	6.14e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.31e-06	6.13e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.3e-06	6.11e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2.2e-06	5.82e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—Alzheimer's disease	2.19e-06	5.81e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.16e-06	5.73e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.16e-06	5.72e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.14e-06	5.68e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.12e-06	5.62e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.11e-06	5.61e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	2.02e-06	5.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.97e-06	5.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.81e-06	4.79e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.78e-06	4.72e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.77e-06	4.71e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.74e-06	4.62e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.65e-06	4.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.63e-06	4.33e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.63e-06	4.32e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.62e-06	4.31e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.62e-06	4.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.59e-06	4.23e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.53e-06	4.05e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-06	3.98e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-06	3.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.48e-06	3.93e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.47e-06	3.9e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-06	3.62e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.06e-06	2.82e-05	CbGpPWpGaD
